NCT03323268View on ClinicalTrials.gov

Use of Exhaled Carbon Dioxyde for Monitoring the Native Cardiac Function During Mechanical Circulatory Support With Venoarterial By-pass in Intensive Care Unit

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 12, 2016

Primary Completion Date

October 23, 2016

Study Completion Date

October 23, 2017

Conditions

Residual Cardiac Output During PVA-ECMO

Interventions

DEVICE

PetCO2 monitoring

CO2 analyzer on ventilator expiratory lane. On-line, continuous, and noninvasive monitor. Routine use in anesthesia and intensive care units.

Trial Locations (1)

34295

JACOB, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER

NCT03323268 - Use of Exhaled Carbon Dioxyde for Monitoring the Native Cardiac Function During Mechanical Circulatory Support With Venoarterial By-pass in Intensive Care Unit | Biotech Hunter | Biotech Hunter